Login
$SRCO
$0.08 +$0.00 (0.0%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q1 FY2027
As of Jul 31, 2026
Q4 FY2026
As of Apr 30, 2026
Q3 FY2026
As of Jan 31, 2026
Q2 FY2026
As of Oct 31, 2025
Q1 FY2026
As of Jul 31, 2025
Q4 FY2025
As of Apr 30, 2025
Q3 FY2025
As of Jan 31, 2025
Q2 FY2025
As of Oct 31, 2024
Q1 FY2025
As of Jul 31, 2024
Q4 FY2024
As of Apr 30, 2024
Q3 FY2024
As of Jan 31, 2024
Q2 FY2024
As of Oct 31, 2023
Q1 FY2024
As of Jul 31, 2023
Q4 FY2023
As of Apr 30, 2023
Q1 FY2023
As of Jul 31, 2022
Q4 FY2022
As of Apr 30, 2022
Q3 FY2022
As of Jan 31, 2022
Q2 FY2022
As of Oct 31, 2021
Q1 FY2022
As of Jul 31, 2021
Q4 FY2021
As of Apr 30, 2021
ASSETS
Current Assets
Cash and cash equivalents
Accounts receivable
Inventory
Other current assets
Prepaid expenses
Merchant advances (less provision of $857,052 and $751,152, respectively)
Total Current Assets
Rent deposit
Total assets
LIABILITIES AND DEFICIT
Liabilities:
Current Liabilities
Bank overdraft
Accounts payable and accrued expenses
Short Term Loan
Current portion notes payable
Loans payable-related parties
Derivative liabilities
Total Current Liabilities
Long Term Liabilities
Loans payable-related parties
Related Party
Nonrelated Party
Total loans payable-related parties
Notes payable- net of current portion
Related Party
Total notes payable- net of current portion
Note Payable – long term
Total Long Term Liabilities
Total liabilities
Stockholders’ Deficit:
Preferred stock value
Series A Redeemable, Convertible Preferred Stock
Series A Convertible Preferred Stock
Series C Preferred Stock
Series D Preferred Stock
Series C Convertible Preferred Stock
Series D Convertible Preferred Stock
Series C Redeemable Convertible Preferred Stock
Series D Redeemable Convertible Preferred Stock
Common stock, $0.001 par value; 750,000,000 shares authorized, and 54,636,926 and 53,602,565 shares issued and outstanding as of July 31, 2026 and April 30, 2026, respectively
Common stock to be issued 34,028,221 and 33,612,875 as of April 30, 2026 and April 30, 2025, respectively
Common stock to be issued, 35,434,706 and 34,028,221 as of July 31, 2026 and April 30, 2026, respectively
Additional paid-in-capital
Additional paid-in-capital- reserves
Subscriptions Receivable
Accumulated deficit
Total deficiency in stockholders’ equity
Non-controlling interest
Deficit
Total Deficit
Total Liabilities and Deficit

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support